Information Today, Inc. Corporate Site KMWorld CRM Media Streaming Media Faulkner Speech Technology Unisphere/DBTA
PRIVACY/COOKIES POLICY
Other ITI Websites
American Library Directory Boardwalk Empire Database Trends and Applications DestinationCRM Faulkner Information Services Fulltext Sources Online InfoToday Europe KMWorld Literary Market Place Plexus Publishing Smart Customer Service Speech Technology Streaming Media Streaming Media Europe Streaming Media Producer Unisphere Research



News & Events > NewsBreaks
 



Back Index Forward
Twitter RSS Feed
Weekly News Digest

May 26, 2009 — In addition to this week's NewsBreaks article and the monthly NewsLink Spotlight, Information Today, Inc. (ITI) offers Weekly News Digests that feature recent product news and company announcements. Watch for additional coverage to appear in the next print issue of Information Today. For other up-to-the-minute news, check out ITI’s Twitter account: @ITINewsBreaks.

CLICK HERE to view more Weekly News Digest items.

Thomson Reuters Joins Fight Against Swine Flu

The Healthcare and Science Business of Thomson Reuters is offering free access to its Disease Briefing on Influenza (via Prous Science Integrity) to keep the global healthcare community informed about swine flu, or influenza A (H1N1). The daily briefing, which can be downloaded from http://science.thomsonreuters.com/pharma/h1n1, gives readers updates on the flu, including topics such as the development pipeline for related drugs and vaccines, the number of laboratory-confirmed cases, and the international response to the outbreak.

Disease briefings are executive summaries of the current status and future trends in drug therapy for a disease or disorder. Among the topics discussed are risk factors, prevalence and incidence, morbidity and mortality figures, and cost. The briefings also feature a structured, scientific approach to drug R&D for diagnosis, prevention, and treatment of a disease or disorder.

The data in the disease briefings comes from a drug R&D approach designed for life sciences researchers; these are not the medical or epidemiological approaches used elsewhere. The briefings also focus on drugs and vaccinations that are either in the development pipeline or on the market already.

Source: Thomson Reuters



Send correspondence concerning the Weekly News Digest to NewsBreaks Editor Brandi Scardilli
Comments Add A Comment

              Back to top